Hydroxychloroquine for COVID 19 in moderately to severely ill hospitalized patients

Registry ID

EUCTR2020-001270-29

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE3

Sponsor

sanofi-aventis recherche & développement

Start date

2020-04-03

Completion date

2020-06-22

Last update

2026-08-16

Conditions

• Coronavirus infection

Summary

Evaluate the effect of hydroxychloroquine (HCQ) + standard of care as compared to standard of care only on oxygen saturation/fraction of inspired oxygen (SpO2/FiO2) ratio in adult patients hospitalized with moderate to severe Coronavirus Disease 2019 (COVID-19)

Locations

• , , Denmark
• , , Germany
• , , UK
• , , Czechia
• , , France

View on source registry